A carregar...
Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast Cancer
Genetic alterations in circulating tumor DNA (ctDNA) are an emerging biomarker for the early detection of relapse and have the potential to guide targeted treatment. ctDNA analysis is often performed by droplet digital PCR; however, next-generation sequencing (NGS) allows multigene testing without h...
Na minha lista:
| Publicado no: | Case Rep Oncol Med |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6754891/ https://ncbi.nlm.nih.gov/pubmed/31583146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6545298 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|